Overview
This page documents a verified case of a civilian Targeted Individual with surgically implanted microchips discovered through medical imaging, demonstrating the covert implantation program targeting unvaccinated individuals since at least 2002.
Patient Profile: 52-year-old law-abiding civilian male who was in a car crash in 2002 requiring surgery for broken bones. During the surgical procedure, he received multiple microchip implants without his knowledge or consent.
Medical Documentation Evidence
Radiological Findings
Multiple imaging studies confirmed implanted microchips at specific anatomical locations:
- Microchip #1: Circled on initial radiology scan (location unspecified in source)
- Microchip #2: Base of sacrum region
- Microchip #3: Brain location confirmed by high-definition brain PET scan showing the same implant site
- Microchip #4: Right iliac crest area
H-SCADA Full Body Scan Results
The patient underwent an H-SCADA full body scan that located frequency emissions from the microchip implants. The report documented:
> "frequency emissions indicate the presence of a sensor/ electronic device, several have semiconductor capacity"
This confirms the implants are active electronic devices with semiconductor functionality.
Live Blood Analysis Findings (Pre-Treatment)
Dr. Ana Maria Mihalcea performed live blood analysis on Day 1 at her clinic, revealing:
- Self-assembling nanotechnology with mesogen microchip assembly in the bloodstream
- Significant rouleaux formation surrounding the technology
- Oxidative stress indicators suggesting energy harvesting activity
Physical Torture Evidence
The patient presented with:
- Microwave burn marks on face and body (documented images)
- Daily torture experience described as "feeling like being electrocuted from the inside"
- Continuous derogatory Voice-to-Skull torture requiring superhuman endurance
- Prayer-based coping mechanisms to ignore constant head torture
Treatment Protocol and Outcomes
Four-Day Intensive IV Therapy
The patient received:
1. IV EDTA Chelation with Vitamin C, Glutathione, Plaquex, Methylene Blue, DMSO, and additional compounds
2. Tesla Plasma machine therapy daily - instructed to hold lightbulbs directly over known microchip locations
3. Additional therapeutic interventions as documented by Dr. Mihalcea
Treatment Outcomes
After 4 days of intensive treatment:
- Significant reduction in Voice-to-Skull torture volume and severity
- Decreased microwave torture intensity, pain, frequency, and severity
- Blood analysis showed reduced polymer microchips and filaments
- No polymer filaments or microchips visible on Day 4 live blood analysis at 200x magnification
- Improved cell membrane strength with restored electromagnetic capacity (shimmering gold within cells)
- Reduced rouleaux formation in bloodstream
Tesla Plasma Machine Evidence
Mariano from the Tzla Club sent Dr. Mihalcea a microscopic image of a microchip that came out of skin after using the Tesla machine:
> "Microchip from a COVID19 unvaccinated individual that came out with the Plasma healing machine. Image taken with smartphone cam macro mode attached to the microscope. Magnification is 120x"
Related Entities and Concepts
- targeted-individuals-neurostrikes-framework — Framework classifying neurostrike victims as "Uncompensated Bio-Laborers" under TVPA, with evidence from patent-based corporate accountability
- havana-syndrome-evidence — Documented neurostrike evidence from December 2016 Cuba outbreak affecting over 40 U.S. government personnel, with 24 diagnosed with brain damage
- unacknowledged-special-access-programs — Most secretive tier of U.S. military/intelligence operations requiring greater protection than acknowledged SAPs, serving as testing grounds for neurotechnology on civilian populations
- disclosure-project-secrecy-architecture — Analysis of how UFO secrecy has evolved from conventional denial to USAPS and privatized corporate-industrial operations
- special-access-programs — SAP protection levels (Acknowledged/Unacknowledged/Waived-Unacknowledged), control systems for SCI, and dissemination controls